Results
46
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
46 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
AYRO | US$0.65 | 0.5% | -63.1% | US$4.5m | n/a | PS20.1x | n/a | n/a | ||
MOD | US$105.14 | 7.1% | 53.3% | US$5.2b | US$147.35 | PE34.5x | E29.8% | n/a | ||
SLDP | US$1.37 | -3.5% | -11.0% | US$248.9m | US$2.00 | PS13.7x | E1.6% | n/a | ||
WGO | US$45.97 | -1.9% | -31.0% | US$1.3b | US$62.92 | PS0.5x | E41.0% | 3.0% | ||
MBLY | US$16.15 | 0.9% | -39.4% | US$12.9b | US$19.97 | PS7.9x | E103.7% | n/a | ||
ELEK | US$0.017 | -18.9% | 81.3% | US$7.7m | n/a | PB12.3x | n/a | n/a | ||
LI | US$23.37 | 1.0% | -22.8% | US$24.2b | US$30.20 | PE16.7x | E21.0% | n/a | ||
CAAS | US$4.10 | -1.2% | 26.5% | US$126.2m | n/a | PE3.9x | n/a | 19.5% | ||
CDTI | US$0.40 | 0% | -31.0% | US$2.0m | n/a | PE1.7x | n/a | n/a | ||
GNTX | US$25.30 | -9.1% | -26.8% | US$5.8b | US$32.79 | PE14.2x | E9.3% | 1.9% | ||
XPEL | US$42.51 | 0.6% | -18.4% | US$1.1b | US$55.33 | PE24.2x | E15.4% | n/a | ||
STRT | US$36.42 | -5.4% | 43.3% | US$147.0m | US$45.00 | PE9.2x | E-19.3% | 0% | ||
THO | US$102.26 | -0.3% | -11.1% | US$5.4b | US$107.82 | PE25.9x | E23.2% | 2.0% | ||
QS | US$4.99 | -2.2% | -31.6% | US$2.6b | US$6.14 | PB2.3x | E19.8% | n/a | ||
TSLA | US$378.17 | -2.8% | 101.6% | US$1.3t | US$329.16 | PE170.6x | E22.3% | n/a | ||
WKSP | US$0.93 | -9.9% | -33.2% | US$30.9m | US$1.67 | PS4.8x | E41.4% | n/a | ||
THRM | US$37.73 | -4.1% | -21.9% | US$1.2b | US$58.80 | PE17.3x | E23.9% | n/a | ||
DORM | US$130.65 | -1.3% | 60.5% | US$4.0b | US$138.50 | PE21.5x | E10.6% | n/a | ||
SMP | US$31.21 | 0.4% | -22.3% | US$672.3m | US$40.50 | PE11x | S2.2% | 3.7% | ||
MTEN | US$5.32 | 13.0% | n/a | US$32.3m | n/a | PE48.7x | n/a | n/a | ||
PHIN | US$51.45 | 3.0% | 70.9% | US$2.1b | US$56.75 | PE20.2x | E26.4% | 1.9% | ||
SYPR | US$2.34 | 15.3% | 21.2% | US$50.9m | n/a | PS0.4x | n/a | 0% | ||
RIVN | US$12.77 | 2.8% | -15.8% | US$13.1b | US$14.82 | PS2.9x | E16.4% | n/a | ||
LCID | US$2.91 | 9.0% | -13.9% | US$8.8b | US$2.77 | PS12x | E26.3% | n/a |